The Independent Voice of
European Private Equity

Advanced Search

MVM re-invests in Heptares Therapeutics

Real Deals 6 March 2008

MVM Life Science Partners has invested a second tranche of seed funding in drug discovery company Heptares Therapeutics.

Next article »

« Previous article

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19